首页> 外国专利> METHOD FOR DIAGNOSTICS OF IRON METABOLISM DISORDERS IN SEVERE FORMS OF COVID-19

METHOD FOR DIAGNOSTICS OF IRON METABOLISM DISORDERS IN SEVERE FORMS OF COVID-19

机译:Covid-19严重形式的铁代谢障碍诊断方法

摘要

FIELD: medicine; resuscitation; infectology.;SUBSTANCE: invention relates to medicine, namely to resuscitation and infectology, it can be used to diagnose iron metabolism disorders in severe forms of COVID-19. In the patient's organism, non-transferrin-related iron (NTBI) is determined. After intramuscular injection of deferoxamine to patients, the daily excretion of iron in the urine is determined by inductively coupled plasma mass spectrometry. At its concentration in the urine of 1000 mg/l and above, severe iron metabolism disorders are diagnosed. ;EFFECT: method makes it possible to diagnose iron metabolism disorders in COVID-19 by determining free iron in the patient's urine, collected during the day, when the patient is injected with deferoxamine, which allows detecting increased excretion of iron in the urine.;1 cl, 2 ex
机译:领域:医学;复苏;感染学。物质:发明涉及药物,即复苏和感染学,可用于以严重形式的Covid-19诊断铁代谢紊乱。在患者的生物体中,确定非转化素相关的铁(NTBI)。在患有患者的Deferoxamine肌内注射后,通过电感耦合等离子体质谱法测定尿液中的铁的日常排泄。在尿液中浓度为1000mg / L及以上,诊断严重的铁代谢障碍。 ;效果:方法可以通过在白天收集的患者尿液中的游离铁来诊断Covid-19中的铁代谢紊乱,当患者注射脱硫胺时,这允许检测尿液中的铁的排泄增加。 1 cl,2前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号